Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Depreciation & Amortization (CF) (2020 - 2021)

Ensysce Biosciences (ENSC) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $50.0 as the latest value for Q3 2021.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 2.04% to $50.0 in Q3 2021 year-over-year; TTM through Jun 2022 was $50.0, a 75.25% decrease, with the full-year FY2021 number at $151.0, down 24.88% from a year prior.
  • Depreciation & Amortization (CF) was $50.0 for Q3 2021 at Ensysce Biosciences, roughly flat from $50.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $52.0 in Q4 2020 to a low of $49.0 in Q3 2020.